RTW INVESTMENTS, LP
Institutional investor · Portfolio as of Q3 2021
Top Holdings120 positions
ROCKET PHARMACEUTICALS INC | 15.8M | $469.6M | 7.1% | $18.70 | +60.16% | 11 qtrssince 2019-Q1 | Increased 64 |
State Street Spdr S&p 500 Etf Trust TR UNIT | 873,255 | $374.7M | 5.7% | $371.30 | +10.29% | 3 qtrssince 2021-Q1 | Decreased 0 |
ALNYLAM PHARMACEUTICALS INC | 1.7M | $317.8M | 4.8% | $81.30 | +118.28% | 11 qtrssince 2019-Q1 | Unchanged 0 |
MIRATI THERAPEUTICS INC | 1.5M | $264M | 4.0% | — | — | 11 qtrssince 2019-Q1 | Increased 58 |
Thermo Fisher Scientific Inc | 416,000 | $237.7M | 3.6% | $572.96 | 0.00% | 1 qtr | New 85 |
MASIMO CORP | 832,540 | $225.4M | 3.4% | $193.60 | +39.68% | 11 qtrssince 2019-Q1 | Increased 57 |
Vericel Corporation | 4.5M | $220.5M | 3.3% | $17.25 | +179.50% | 11 qtrssince 2019-Q1 | Unchanged 0 |
CELLDEX THERAPEUTICS INC NEW COM NEW | 3.9M | $211M | 3.2% | $14.15 | +267.19% | 6 qtrssince 2020-Q2 | Unchanged 0 |
NATERA INC | 1.9M | $207.5M | 3.1% | $44.14 | +152.49% | 9 qtrssince 2019-Q3 | Increased 61 |
PTC THERAPEUTICS INC | 5.3M | $197M | 3.0% | $41.64 | -11.03% | 11 qtrssince 2019-Q1 | Unchanged 0 |
ILLUMINA INC | 482,791 | $195.8M | 3.0% | $334.89 | +19.56% | 5 qtrssince 2020-Q3 | Unchanged 0 |
ESTABLISHMENT LABS HLDGS INC COM | 2.3M | $166M | 2.5% | $21.90 | +210.52% | 11 qtrssince 2019-Q1 | Unchanged 0 |
DICERNA PHARMACEUTICALS INC | 7.6M | $152.9M | 2.3% | — | — | 11 qtrssince 2019-Q1 | Increased 52 |
TANDEM DIABETES CARE INC | 1.2M | $138.6M | 2.1% | $80.01 | +49.88% | 7 qtrssince 2020-Q1 | Increased 52 |
Globus Med Inc | 1.7M | $128M | 1.9% | $64.85 | +21.66% | 4 qtrssince 2020-Q4 | Unchanged 0 |
AXONICS INC | 1.9M | $126.5M | 1.9% | — | — | 11 qtrssince 2019-Q1 | Unchanged 0 |
AVIDITY BIOSCIENCES INC | 4.8M | $118.1M | 1.8% | $26.39 | -12.35% | 6 qtrssince 2020-Q2 | Increased 56 |
GUARDANT HEALTH INC | 925,342 | $115.7M | 1.7% | $119.32 | +4.76% | 5 qtrssince 2020-Q3 | Increased 48 |
C4 Therapeutics Inc | 2.5M | $111.5M | 1.7% | $37.61 | +27.56% | 4 qtrssince 2020-Q4 | Increased 55 |
IVERIC BIO INC | 6.7M | $109.2M | 1.6% | — | — | 6 qtrssince 2020-Q2 | Unchanged 0 |
RTW INVESTMENTS, LP manages $6.6B across 120 positions as of Q3 2021. Top holdings: RCKT (7.1%), SPY (5.7%), ALNY (4.8%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 20 new positions, 13 exits, 25 increased. Top move: TMO (NEW, conviction 85). Portfolio: $6.6B across 120 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR